Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Macular Degeneration Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Macular Degeneration Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Lucentis 1.4.3 Eylea 1.4.4 Avastin 1.4.5 Squalamine 1.4.6 Conercept 1.4.7 Lampalizamab 1.4.8 Other 1.5 Market by Application 1.5.1 Global Macular Degeneration Drugs Market Share by Application: 2020 VS 2026 1.5.2 50-60 Years Old 1.5.3 60-70 Years Old 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Macular Degeneration Drugs Market Perspective (2015-2026) 2.2 Macular Degeneration Drugs Growth Trends by Regions 2.2.1 Macular Degeneration Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Macular Degeneration Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Macular Degeneration Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Macular Degeneration Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Macular Degeneration Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Macular Degeneration Drugs Players by Market Size 3.1.1 Global Top Macular Degeneration Drugs Players by Revenue (2015-2020) 3.1.2 Global Macular Degeneration Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Macular Degeneration Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Macular Degeneration Drugs Market Concentration Ratio 3.2.1 Global Macular Degeneration Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Macular Degeneration Drugs Revenue in 2019 3.3 Macular Degeneration Drugs Key Players Head office and Area Served 3.4 Key Players Macular Degeneration Drugs Product Solution and Service 3.5 Date of Enter into Macular Degeneration Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Macular Degeneration Drugs Historic Market Size by Type (2015-2020) 4.2 Global Macular Degeneration Drugs Forecasted Market Size by Type (2021-2026) 5 Macular Degeneration Drugs Breakdown Data by Application (2015-2026) 5.1 Global Macular Degeneration Drugs Market Size by Application (2015-2020) 5.2 Global Macular Degeneration Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Macular Degeneration Drugs Market Size (2015-2020) 6.2 Macular Degeneration Drugs Key Players in North America (2019-2020) 6.3 North America Macular Degeneration Drugs Market Size by Type (2015-2020) 6.4 North America Macular Degeneration Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Macular Degeneration Drugs Market Size (2015-2020) 7.2 Macular Degeneration Drugs Key Players in Europe (2019-2020) 7.3 Europe Macular Degeneration Drugs Market Size by Type (2015-2020) 7.4 Europe Macular Degeneration Drugs Market Size by Application (2015-2020) 8 China 8.1 China Macular Degeneration Drugs Market Size (2015-2020) 8.2 Macular Degeneration Drugs Key Players in China (2019-2020) 8.3 China Macular Degeneration Drugs Market Size by Type (2015-2020) 8.4 China Macular Degeneration Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Macular Degeneration Drugs Market Size (2015-2020) 9.2 Macular Degeneration Drugs Key Players in Japan (2019-2020) 9.3 Japan Macular Degeneration Drugs Market Size by Type (2015-2020) 9.4 Japan Macular Degeneration Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Macular Degeneration Drugs Market Size (2015-2020) 10.2 Macular Degeneration Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Macular Degeneration Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Macular Degeneration Drugs Market Size by Application (2015-2020) 11 India 11.1 India Macular Degeneration Drugs Market Size (2015-2020) 11.2 Macular Degeneration Drugs Key Players in India (2019-2020) 11.3 India Macular Degeneration Drugs Market Size by Type (2015-2020) 11.4 India Macular Degeneration Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Macular Degeneration Drugs Market Size (2015-2020) 12.2 Macular Degeneration Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Macular Degeneration Drugs Market Size by Type (2015-2020) 12.4 Central & South America Macular Degeneration Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Novartis 13.1.1 Novartis Company Details 13.1.2 Novartis Business Overview and Its Total Revenue 13.1.3 Novartis Macular Degeneration Drugs Introduction 13.1.4 Novartis Revenue in Macular Degeneration Drugs Business (2015-2020)) 13.1.5 Novartis Recent Development 13.2 Bayer Healthcare 13.2.1 Bayer Healthcare Company Details 13.2.2 Bayer Healthcare Business Overview and Its Total Revenue 13.2.3 Bayer Healthcare Macular Degeneration Drugs Introduction 13.2.4 Bayer Healthcare Revenue in Macular Degeneration Drugs Business (2015-2020) 13.2.5 Bayer Healthcare Recent Development 13.3 Roche 13.3.1 Roche Company Details 13.3.2 Roche Business Overview and Its Total Revenue 13.3.3 Roche Macular Degeneration Drugs Introduction 13.3.4 Roche Revenue in Macular Degeneration Drugs Business (2015-2020) 13.3.5 Roche Recent Development 13.4 Neurotech Pharmaceuticals 13.4.1 Neurotech Pharmaceuticals Company Details 13.4.2 Neurotech Pharmaceuticals Business Overview and Its Total Revenue 13.4.3 Neurotech Pharmaceuticals Macular Degeneration Drugs Introduction 13.4.4 Neurotech Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2015-2020) 13.4.5 Neurotech Pharmaceuticals Recent Development 13.5 Regeneron Pharmaceuticals 13.5.1 Regeneron Pharmaceuticals Company Details 13.5.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue 13.5.3 Regeneron Pharmaceuticals Macular Degeneration Drugs Introduction 13.5.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2015-2020) 13.5.5 Regeneron Pharmaceuticals Recent Development 13.6 Allergan 13.6.1 Allergan Company Details 13.6.2 Allergan Business Overview and Its Total Revenue 13.6.3 Allergan Macular Degeneration Drugs Introduction 13.6.4 Allergan Revenue in Macular Degeneration Drugs Business (2015-2020) 13.6.5 Allergan Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Macular Degeneration Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Macular Degeneration Drugs Revenue Table 3. Ranking of Global Top Macular Degeneration Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Macular Degeneration Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Lucentis Table 6. Key Players of Eylea Table 7. Key Players of Avastin Table 8. Key Players of Squalamine Table 9. Key Players of Conercept Table 10. Key Players of Lampalizamab Table 11. Key Players of Other Table 12. Global Macular Degeneration Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Macular Degeneration Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Macular Degeneration Drugs Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Macular Degeneration Drugs Market Share by Regions (2015-2020) Table 16. Global Macular Degeneration Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Macular Degeneration Drugs Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Macular Degeneration Drugs Market Growth Strategy Table 22. Main Points Interviewed from Key Macular Degeneration Drugs Players Table 23. Global Macular Degeneration Drugs Revenue by Players (2015-2020) (Million US$) Table 24. Global Macular Degeneration Drugs Market Share by Players (2015-2020) Table 25. Global Top Macular Degeneration Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Degeneration Drugs as of 2019) Table 26. Global Macular Degeneration Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Macular Degeneration Drugs Product Solution and Service Table 29. Date of Enter into Macular Degeneration Drugs Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 32. Global Macular Degeneration Drugs Market Size Share by Type (2015-2020) Table 33. Global Macular Degeneration Drugs Revenue Market Share by Type (2021-2026) Table 34. Global Macular Degeneration Drugs Market Size Share by Application (2015-2020) Table 35. Global Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 36. Global Macular Degeneration Drugs Market Size Share by Application (2021-2026) Table 37. North America Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 38. North America Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 39. North America Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 40. North America Macular Degeneration Drugs Market Share by Type (2015-2020) Table 41. North America Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 42. North America Macular Degeneration Drugs Market Share by Application (2015-2020) Table 43. Europe Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 45. Europe Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 46. Europe Macular Degeneration Drugs Market Share by Type (2015-2020) Table 47. Europe Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 48. Europe Macular Degeneration Drugs Market Share by Application (2015-2020) Table 49. China Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 50. China Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 51. China Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 52. China Macular Degeneration Drugs Market Share by Type (2015-2020) Table 53. China Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 54. China Macular Degeneration Drugs Market Share by Application (2015-2020) Table 55. Japan Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 57. Japan Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 58. Japan Macular Degeneration Drugs Market Share by Type (2015-2020) Table 59. Japan Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 60. Japan Macular Degeneration Drugs Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 63. Southeast Asia Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Macular Degeneration Drugs Market Share by Type (2015-2020) Table 65. Southeast Asia Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Macular Degeneration Drugs Market Share by Application (2015-2020) Table 67. India Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 68. India Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 69. India Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 70. India Macular Degeneration Drugs Market Share by Type (2015-2020) Table 71. India Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 72. India Macular Degeneration Drugs Market Share by Application (2015-2020) Table 73. Central & South America Key Players Macular Degeneration Drugs Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Macular Degeneration Drugs Market Share (2019-2020) Table 75. Central & South America Macular Degeneration Drugs Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Macular Degeneration Drugs Market Share by Type (2015-2020) Table 77. Central & South America Macular Degeneration Drugs Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Macular Degeneration Drugs Market Share by Application (2015-2020) Table 79. Novartis Company Details Table 80. Novartis Business Overview Table 81. Novartis Product Table 82. Novartis Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 83. Novartis Recent Development Table 84. Bayer Healthcare Company Details Table 85. Bayer Healthcare Business Overview Table 86. Bayer Healthcare Product Table 87. Bayer Healthcare Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 88. Bayer Healthcare Recent Development Table 89. Roche Company Details Table 90. Roche Business Overview Table 91. Roche Product Table 92. Roche Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 93. Roche Recent Development Table 94. Neurotech Pharmaceuticals Company Details Table 95. Neurotech Pharmaceuticals Business Overview Table 96. Neurotech Pharmaceuticals Product Table 97. Neurotech Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 98. Neurotech Pharmaceuticals Recent Development Table 99. Regeneron Pharmaceuticals Company Details Table 100. Regeneron Pharmaceuticals Business Overview Table 101. Regeneron Pharmaceuticals Product Table 102. Regeneron Pharmaceuticals Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 103. Regeneron Pharmaceuticals Recent Development Table 104. Allergan Company Details Table 105. Allergan Business Overview Table 106. Allergan Product Table 107. Allergan Revenue in Macular Degeneration Drugs Business (2015-2020) (Million US$) Table 108. Allergan Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Macular Degeneration Drugs Market Share by Type: 2020 VS 2026 Figure 2. Lucentis Features Figure 3. Eylea Features Figure 4. Avastin Features Figure 5. Squalamine Features Figure 6. Conercept Features Figure 7. Lampalizamab Features Figure 8. Other Features Figure 9. Global Macular Degeneration Drugs Market Share by Application: 2020 VS 2026 Figure 10. 50-60 Years Old Case Studies Figure 11. 60-70 Years Old Case Studies Figure 12. Other Case Studies Figure 13. Macular Degeneration Drugs Report Years Considered Figure 14. Global Macular Degeneration Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 15. Global Macular Degeneration Drugs Market Share by Regions: 2020 VS 2026 Figure 16. Global Macular Degeneration Drugs Market Share by Regions (2021-2026) Figure 17. Porter's Five Forces Analysis Figure 18. Global Macular Degeneration Drugs Market Share by Players in 2019 Figure 19. Global Top Macular Degeneration Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Macular Degeneration Drugs as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Macular Degeneration Drugs Revenue in 2019 Figure 21. North America Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Europe Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. China Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Japan Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Southeast Asia Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. India Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Central & South America Macular Degeneration Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Novartis Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 30. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Bayer Healthcare Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Roche Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 34. Neurotech Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Neurotech Pharmaceuticals Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 36. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Regeneron Pharmaceuticals Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 38. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Allergan Revenue Growth Rate in Macular Degeneration Drugs Business (2015-2020) Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed

Novartis Bayer Healthcare Roche Neurotech Pharmaceuticals Regeneron Pharmaceuticals Allergan